Postdoctoral Program

March 20, 2026 Ukg Pro Recruiting (Formerly Ultipro)

Postdoctoral Program

Postdoctoral program

As a leader in Genetic Medicines, we are delighted to offer unique postdoctoral and clinical fellowships to scientists and clinicians in fields such as:

Chemistry
Cell Biology
Biochemistry
Toxicology
Pharmacology
Pharmaceutical Development
Clinical Development

Testimonials

Why Ionis?

Key Advantages

At Ionis, our postdoctoral researchers work with world-class scientists and our academic collaborators to discover and develop new RNA-targeted therapeutics. Our scientists consistently publish in prestigious peer-reviewed journals, participate in key scientific meetings in many different areas of biomedical research, oligonucleotide chemistry, and drug development.

A fellowship at Ionis typically lasts two years, with the potential for a third-year extension. If you’re interested in becoming a part of cutting-edge science in a research-focused and resource-rich environment, while making a contribution to advancing antisense drug development technologies, Ionis Pharmaceuticals is the place for you.

Benefits include:

Medical/dental/
vision plans
3 weeks of vacation, 
16 holidays and 2 weeks of sick pay
401 (K) plan
Life insurance

“Being able to visually see the benefits of your work each and every day while pursuing and committing to scientific discoveries for those in the world that need it the most, make this fellowship one-of-a-kind.”

— Joseph Ochaba, Ph.D.

Postdoctoral Fellow, Antisense Drug Discovery

Postdoctoral & Clinical Fellowship Opportunities

At Ionis, we have a passion for helping people with serious diseases and driving the science that impacts their future. Learn more and explore our postdoctoral and clinical fellowship opportunities.

Apply on company site

How to Get Hired at Ionis Pharmaceuticals

  • Ionis runs UKG Pro Recruiting at recruiting.ultipro.com/ISI1000ISIS — the legacy ISIS in the URL is the original company name, not a misconfiguration.
  • Wainua (eplontersen, with AstraZeneca) and Olezarsen launches make 2025 and 2026 the most commercially active period in Ionis history; expect heavy hiring across cardiology field force, medical affairs, and patient services.
Read the full guide

How well do you match this role?

Check My Resume